[go: up one dir, main page]

GB201420910D0 - Pyrrolobenzodiazepine-antibody conjugates - Google Patents

Pyrrolobenzodiazepine-antibody conjugates

Info

Publication number
GB201420910D0
GB201420910D0 GBGB1420910.0A GB201420910A GB201420910D0 GB 201420910 D0 GB201420910 D0 GB 201420910D0 GB 201420910 A GB201420910 A GB 201420910A GB 201420910 D0 GB201420910 D0 GB 201420910D0
Authority
GB
United Kingdom
Prior art keywords
pyrrolobenzodiazepine
antibody conjugates
conjugates
antibody
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB1420910.0A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
ADC Therapeutics SA
Original Assignee
ADC Therapeutics SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ADC Therapeutics SA filed Critical ADC Therapeutics SA
Priority to GBGB1420910.0A priority Critical patent/GB201420910D0/en
Publication of GB201420910D0 publication Critical patent/GB201420910D0/en
Priority to JP2017546038A priority patent/JP6878287B2/en
Priority to EP15801398.7A priority patent/EP3223854A1/en
Priority to US15/529,622 priority patent/US10780096B2/en
Priority to AU2015352545A priority patent/AU2015352545B2/en
Priority to CN201580072448.7A priority patent/CN107148285B/en
Priority to KR1020177014301A priority patent/KR20170101895A/en
Priority to NZ731782A priority patent/NZ731782A/en
Priority to BR112017011111A priority patent/BR112017011111A2/en
Priority to PCT/EP2015/077684 priority patent/WO2016083468A1/en
Priority to CA2968447A priority patent/CA2968447A1/en
Priority to MX2017006770A priority patent/MX379396B/en
Priority to ZA2017/04297A priority patent/ZA201704297B/en
Priority to US17/006,681 priority patent/US20210113587A1/en
Priority to JP2021075528A priority patent/JP2021121595A/en
Ceased legal-status Critical Current

Links

GBGB1420910.0A 2014-11-25 2014-11-25 Pyrrolobenzodiazepine-antibody conjugates Ceased GB201420910D0 (en)

Priority Applications (15)

Application Number Priority Date Filing Date Title
GBGB1420910.0A GB201420910D0 (en) 2014-11-25 2014-11-25 Pyrrolobenzodiazepine-antibody conjugates
MX2017006770A MX379396B (en) 2014-11-25 2015-11-25 PYRROLOBENZODIAZEPINE ANTIBODY CONJUGATES.
KR1020177014301A KR20170101895A (en) 2014-11-25 2015-11-25 Pyrrolobenzodiazepine-antibody conjugates
BR112017011111A BR112017011111A2 (en) 2014-11-25 2015-11-25 pyrrolobenzodiazepine-antibody conjugates
US15/529,622 US10780096B2 (en) 2014-11-25 2015-11-25 Pyrrolobenzodiazepine-antibody conjugates
AU2015352545A AU2015352545B2 (en) 2014-11-25 2015-11-25 Pyrrolobenzodiazepine-antibody conjugates
CN201580072448.7A CN107148285B (en) 2014-11-25 2015-11-25 Pyrrolobenzodiazepine-antibody conjugates
JP2017546038A JP6878287B2 (en) 2014-11-25 2015-11-25 Pyrrolobenzodiazepine-antibody conjugate
NZ731782A NZ731782A (en) 2014-11-25 2015-11-25 Pyrrolobenzodiazepine-antibody conjugates
EP15801398.7A EP3223854A1 (en) 2014-11-25 2015-11-25 Pyrrolobenzodiazepine-antibody conjugates
PCT/EP2015/077684 WO2016083468A1 (en) 2014-11-25 2015-11-25 Pyrrolobenzodiazepine-antibody conjugates
CA2968447A CA2968447A1 (en) 2014-11-25 2015-11-25 Pyrrolobenzodiazepine-antibody conjugates and their use to treat neoplasms
ZA2017/04297A ZA201704297B (en) 2014-11-25 2017-06-23 Pyrrolobenzodiazepine-antibody conjugates
US17/006,681 US20210113587A1 (en) 2014-11-25 2020-08-28 Pyrrolobenzodiazepine-antibody conjugates
JP2021075528A JP2021121595A (en) 2014-11-25 2021-04-28 Pyrrolobenzodiazepine-antibody conjugate

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB1420910.0A GB201420910D0 (en) 2014-11-25 2014-11-25 Pyrrolobenzodiazepine-antibody conjugates

Publications (1)

Publication Number Publication Date
GB201420910D0 true GB201420910D0 (en) 2015-01-07

Family

ID=52292484

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB1420910.0A Ceased GB201420910D0 (en) 2014-11-25 2014-11-25 Pyrrolobenzodiazepine-antibody conjugates

Country Status (1)

Country Link
GB (1) GB201420910D0 (en)

Similar Documents

Publication Publication Date Title
IL285516B (en) Amatoxin-antibody conjugates
ZA201704297B (en) Pyrrolobenzodiazepine-antibody conjugates
PL3119885T3 (en) Antibody-fynomer conjugates
ZA201607385B (en) Anti-ptk7 antibody-drug conjugates
EP3206710A4 (en) Incretin-insulin conjugates
AU361515S (en) Dishrack
AU362944S (en) Lapboard
GB201513607D0 (en) Pyrrolobenzodiazepine-antibody conjugates
IL252618A0 (en) Biomolecule conjugates
EP3152248A4 (en) Dendrimer-drug conjugates
IL246349A0 (en) Factor vii conjugates
IL246713A0 (en) Factor viii conjugates
PL3270711T3 (en) Sugar-dipeptide conjugates
SG10201506686WA (en) Conjugates
GB201420910D0 (en) Pyrrolobenzodiazepine-antibody conjugates
GB201406717D0 (en) Pyrrolobenzodiazepine-Antibody conjugates
GB201406718D0 (en) Pyrrolobenzodiazepine-antibody conjugates
GB201406719D0 (en) Pyrrolobenzodiaepine-antibody conjugates
GB201406720D0 (en) Pyrrolobenzodiazepine-antibody conjugates
GB201518839D0 (en) Conjugates
GB201513605D0 (en) Pyrrolobenzodiazepine-antibody conjugates
AU2014264V (en) FlatGL Templetonia retusa
AU358508S (en) Bedhead
AU2014163V (en) CS004 Callistemon salignus
AU2014902169A0 (en) Dendrimer-drug conjugates

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)